SureTrader Advertisement Advertisement
Home > Boards > US Listed > Biotechs >

Organovo Holdings, Inc. (ONVO)

Add ONVO Price Alert      Hide Sticky   Hide Intro
Moderator: No Moderator dshade
Search This Board:
Last Post: 11/27/2015 7:40:01 AM - Followers: 305 - Board type: Free - Posts Today: 0

     Organovo is a three-dimensional biology company focused on delivering breakthrough bioprinting technology and creating tissue on demand for research and medical applications.
The company's NovoGen three-dimensional bioprinting technology is a platform that works across all tissue and cell types.
Organovo's NovoGen MMX Bioprinter was selected as one of the "Best Inventions of 2010" by TIME Magazine.
Organovo is helping pharmaceutical partners develop human biological disease models in three dimensions that enable therapeutic drug discovery and development.
Organovo's bioprinting technology can also be developed to create surgical tissues direct therapy.
Organovo leads the way in solving complex medical research problems and building the future of medicine.


ONVO Security Details Share Structure

Shares Outstanding 77,816,787 a/o Mar 16, 2014
Float 50,000,000 a/0 May24,2014
Authorized Shares 150,000,000 a/o May24, 2014

IR and Media Contacts:
Investor Relations Contact:
Media Contact:

Mailing Address:
Organovo, Inc.
6275 Nancy Ridge Drive, Suite 110
San Diego, CA 92121
Phone: 1-858-550-9994

For all the latest company information, details, news, please visit

Organovo's Scientific Founder and Chief Scientific Officer, Dr. Gabor Forgacs
is the Executive and Scientific Director of the Shipley Center for Innovation at Clarkson University and the George H. Vineyard Professor of Biological Physics at the University of Missouri.
He developed Organovo's breakthrough organ printing technology while leading a team of top regenerative medicine scientists from multiple universities, with the backing of a $5MM National Science Foundation Grant.
Professor Forgacs is the author of more than 150 peer reviewed journal articles and the textbook Biological Physics of the Developing Embryo, (with Stuart Newman), published by Cambridge University Press.
He holds a PhD in theoretical physics from the Roland Eotvos University, Budapest Hungary. He moved to the United States in the 1980's from the Institute of Physics of the French Atomic Energy Agency in Saclay to accept a professorship at Clarkson University. 
University of Missouri researcher doing groundbreaking work in regenerative medicine. Here is a video:


Organovo strives to advance regenerative medicine to new heights, by enabling bioprinting tissues and 3-D cellular constructs that were not possible before.
The novel and flexible capabilities of the bioprinting technology allow researchers to generate data faster and more efficiently, thus leading to cutting edge scientific findings, publications, and grants.

Organovo's 3-D NovoGen bioprinting technology allows for the placement of cells in any pattern desired.
First, small building blocks of any shape are created from the desired cell type.
Second, these pre-formed cell aggregates are loaded into a print cartridge that is then attached to the bio-printer.
The bioprinter deposits the cell aggregates one layer at a time, creating multiple stacked 2-D patterns.
A non-invasive gel is placed next to the cell aggregates to hold the desired 3-D shape as each layer is placed in 2-D.

After printing, the cell aggregates retain enough cellular mobility for them to flow into one another, creating a fused tissue construct.
The principles of developmental biology, including cellular self-assembly, allow the final construct to mature into the desired shape and properties.


World class support for NovoGen MMX

The NovoGen MMX Bioprinter™ is supported by our scientific and engineering team.
Every customer receives bioprinter training and access to Organovo's scaffold-free proprietary bioprinting process, which includes cell preparation to tissue maturation.
Additional consultation and application support are available upon request. Organovo's success comes from enabling our customers' success.  


NovoGen MMX Bioprinter

    The NovoGen MMX Bioprinter™ is a novel hardware and software platform at the forefront of bioprinting research and development. The NovoGen MMX™ was developed to meet challenges in biological research.
The platform takes primary or other human cells and shapes them into 3D tissue, with tremendous cellular viability and biology that is superior to even an animal model.
The platform is being used by Organovo's Pharma partners today to enable cutting edge research into drug discovery.

By allowing creation of three dimensional biological structures, Organovo creates functional human tissue that is superior to current disease models.
By enabling printing of tissue in a laboratory environment, investigations on the constructs can be integrated into your current analysis methods. (at 28 sec into the video is a full frontal view of the ONVO NovaGen MMX Bioprinter)

  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
Current Price
Bid Ask Day's Range
ONVO News: Organovo Holdings Inc.: 3 Important Takeaways From Earnings 11/20/2015 09:59:02 AM
ONVO News: Organovo Holdings Engineered a Double-Digit Percentage Gain in October -- Here's How 11/11/2015 01:05:02 PM
ONVO News: Quarterly Report (10-q) 11/09/2015 04:15:01 PM
ONVO News: Current Report Filing (8-k) 11/09/2015 04:12:57 PM
ONVO News: These 3 Small Stocks Will Likely Make Huge Moves This Week 11/08/2015 09:20:02 PM
#6071  Sticky Note ONVO Kidney news & Profile videos dshade 05/24/14 12:15:04 PM
#8875   ONVO LOOKING FOR MORE HERE Roy London 11/27/15 07:40:01 AM
#8874   Ready to break it BOLLINGER. :) Rkmatters 11/25/15 12:15:55 PM
#8873   Maybe just some shorts trying to cover on RallyTheMarket 11/25/15 11:40:29 AM
#8872   volume is too low for a short squeeze, IMHO Alvie 11/25/15 10:36:47 AM
#8871   possible short squeeze Roy London 11/25/15 09:01:17 AM
#8870   DDD and SSYS are down like 80% over rayank 11/25/15 06:37:01 AM
#8869   I guess all the geniuses have the answers RandolRocketman 11/24/15 10:52:37 PM
#8868   The future's so bright...I gotta wear shades nsomniyak 11/24/15 06:26:45 PM
#8867   Yeah they were no where to be found, rayank 11/24/15 04:47:36 PM
#8866   Future looks good? Future is so poor and RallyTheMarket 11/24/15 04:07:36 PM
#8865   You seem to like to dwell on the PaperLion 11/24/15 03:10:31 PM
#8864   Where were they when it hit $2? Where RallyTheMarket 11/24/15 01:45:22 PM
#8863   Yeah, it may attract a buy out from rayank 11/24/15 12:28:41 PM
#8862   Not short here. Like I said this one RallyTheMarket 11/24/15 11:51:40 AM
#8861   You may be right, but the chart is rayank 11/24/15 11:42:20 AM
#8860   Look at short interest from Nov-14 through Mar-15. RallyTheMarket 11/24/15 10:02:34 AM
#8859   I wouldn't say they're dropping off like flies RallyTheMarket 11/24/15 09:57:01 AM
#8858   So an upgrade and now a downgrade? Oh rayank 11/24/15 06:44:04 AM
#8857   INVESTARS ANALYST ACTIONS - PUBLIC – 4:07 PM RandolRocketman 11/23/15 11:07:50 PM
#8856   It seems to be stabilizing in the last rayank 11/23/15 04:57:28 PM
#8855   SAN DIEGO, Nov. 23, 2015 (GLOBE NEWSWIRE) -- RandolRocketman 11/23/15 12:59:19 PM
#8854   Shorts dropping like flies. Wonder why? RandolRocketman 11/23/15 12:35:25 PM
#8853   INVESTARS ANALYST ACTIONS - PRIVATE – 7:22 PM RandolRocketman 11/23/15 12:29:37 PM
#8852   From the Motley Fool: Alvie 11/23/15 11:45:55 AM
#8851   That is all good Rally. No one is rayank 11/18/15 03:49:49 PM
#8848   One day this may be a good stock RallyTheMarket 11/18/15 03:20:06 PM
#8847   Now you're confusing good company with good stock. RallyTheMarket 11/18/15 03:14:17 PM
#8846   Some of us are NOT pure traders and PaperLion 11/18/15 03:05:12 PM
#8845   Probably as much as these brought us in RallyTheMarket 11/18/15 02:58:26 PM
#8844   You're trying to say then that we can RallyTheMarket 11/18/15 02:44:10 PM
#8843   Well almost correct: $13-$3, (not $2) but add rayank 11/18/15 12:38:22 PM
#8842   For now you are correct. :-) rayank 11/18/15 12:29:35 PM
#8841   Huh?? Who knows how much revenue that PaperLion 11/18/15 12:23:48 PM
#8840   How much revenue did that award generate? Ridiculous. RallyTheMarket 11/18/15 10:43:36 AM
#8839   Nice award and we are down 5%. Amazing! rayank 11/18/15 09:40:01 AM
#8838   SAN DIEGO, Nov. 18, 2015 (GLOBE NEWSWIRE) -- RandolRocketman 11/18/15 09:14:49 AM
#8837   $ONVO recent news/filings stocktrademan 11/13/15 11:16:53 AM
#8836   Knowing what's coming is icing on the cake. RandolRocketman 11/12/15 09:45:07 PM
#8835   The company told us to. Nothing until mid-2016 RallyTheMarket 11/10/15 01:40:33 PM
#8834   Everyone can go back to ignoring ONVO for Windbag1014 11/10/15 12:55:38 PM
#8833   Everyone can go back to ignoring ONVO for RallyTheMarket 11/10/15 12:49:14 PM
#8832   Organovo Announces Fiscal Second-Quarter Results; Company Affirms Full-Year BuckeyeStocks 11/09/15 04:29:03 PM
#8831   Good spiked with bad, missed on earnings but bettyfordallstar 11/09/15 04:28:30 PM
#8830   Organovo Holdings (NYSEMKT:ONVO): FQ2 EPS of -$0.12 misses BuckeyeStocks 11/09/15 04:21:16 PM
#8829   Monday, November 9, 2015 at 5:00 p.m. Eastern muggel 11/09/15 03:08:13 PM
#8828   Release Date for Fiscal Second-Quarter 2016 Financial Results muggel 11/09/15 01:42:14 PM
#8827   Didn't notice. JMO--There's plenty of interest. ONVO--GLTA![/ dadx4 11/09/15 09:07:29 AM
#8826   For the long term investor, I see this CIMA7 11/09/15 02:01:51 AM
#8825   I care!! Alvie 11/08/15 10:21:26 PM
#8824   Anyone notice no one cares about ONVO anymore? RallyTheMarket 11/06/15 11:34:36 AM